SVRE: Restoring Balance Despite Market Volatility Despite a slew of safety improvements added to vehicles in the U.S. over the past 20 years – like forward collision warnings, emergency braking, lane departure warnings, blind spot detection, backup cameras, etc., nearly 43,000 people died in traffic accidents in 2022 in the U.S., up 30% from 2013.2 Experts agree that there is not one simple explanation for this apparent contradiction where we are driving safer vehicles and yet, traffic fatalities continue to climb. Some of the increase is simply driven by math, because while the U.S. population has grown by 5.4% over the past decade the number of registered vehicles in the U.S. has grown by over 16.8% during the same period. However, there has also been a notable increase in what the NHTSA calls “dangerous driving behaviors” – speeding, impaired driving, and failure to wear a seatbelt – which are pushing traffic fatalities up in the U.S.
Enter the SaverOne Solution
While protecting everyone on the roads from the dangers of distracted driving is an admirable goal, until legislation completely bars access to technology in our vehicles the reality is that economics will drive adoption of tools to prevent distracted driving. In the case of commercial fleets, think bus companies, trucking and delivery companies, the risk of litigation from a single distracted driver incident is so great, that these companies are looking for alternative solutions to eliminate a driver’s access to distracting phone apps. Again, while this technology largely exists in most phones, it requires the driver to actively opt-in, and in the case of commercial vehicles looking to mitigate liability risk, they want to remove the opt-in requirement and instead have a system that automatically limits a driver’s phone to only essential tools to prevent driver distraction.
SaverOne (NASDAQ:SVRE) has built its first commercial product to address just this need by detecting and locating a driver’s cell phone radiofrequency (RF) signal. The company’s first commercial product - an In-Cabin Driver Distraction Prevention Solution (DDPS) branded as the SaverOne system, can identify if a cell phone is in the vicinity of the driver’s seat and with the SaverOne App installed it will block access to the most distracting apps (social media/texting) while still allowing necessary apps like navigation and the ability to make hands-free phone calls. SaverOne is initially deploying this solution for the commercial market so companies operating commercial vehicles, buses, or vehicles provided to employees can mitigate their liability associated with distracted driving.
The company launched this product in 2019 in Israel with several pilot programs and as of August 2023 about 4,300 systems have been ordered and roughly 3,000 of these systems have been installed. The company released a second generation of the distracted driver protection solution in the fourth quarter of 2022, which will target the larger global auto market and in 2023 the company announced its first international sales. We believe that the company is still identifying the best distribution, installation, and marketing strategies for global markets.
Recent financial results and news:
In the first half of 2023, the company reported a sharp jump in year-over-year revenues to roughly $400k as the number of installed systems grew to 3,000 as of August 29, 2023 (up from 1,750 installed units as of 3/31/23). While this growth rate is impressive it is important to note that SaverOne is still a fairly small company and managing its growth as the company moves from initial pilot installations to full fleet installations will be a challenge. The company’s first-half operating loss of $4.8 million was due in large part to the $3.3 million R&D expenditure. The company has indicated that as it develops its OEM solution and VRU product R&D expenditures will likely remain elevated.
Other Notable Milestone:
- The company announced that Electra Afikim (a large public transportation company in Israel) would install the SaverOne System in its entire bus fleet representing roughly 1,200 vehicles, SaverOne’s largest order to-date.
- The company announced a meaningful expansion of its pilot projects outside of Israel with an additional pilot project on buses in the Gulf region; a second pilot project in the U.S.; and its first pilot in Europe.
- In 2022, the company entered into a memorandum of understanding with IVECO (one of the leading medium/heavy truck manufacturers in the world) to integrate its solution within IVECO trucks. This has the potential to be a game-changing agreement for the company based on IVECO’s size (producing over 150,000 vehicles annually).
IPO/Financing:
A little over a year ago, in June 2022, the company closed on its initial public offering of 2.94 million units (consisting of an ADS and one warrant to purchase an ADS) at a price of $4.13 per unit raising roughly $13 million in gross proceeds. Each ADS represents 5 shares of common stock.
In December 2022, the company completed a private placement of 0.8 million ADSs at $1.854 per ADS raising roughly $1.5 million in gross proceeds.
Closing Notes
SaverOne (NASDAQ:SVRE) is an emerging company addressing the challenging issue of cell phone device use inside a moving vehicle. Distracted driving continues to get worse around the globe despite numerous public awareness campaigns. Corporate fleets and commercial transportation companies need tools to limit distracted driving that operate seamlessly without requiring a driver to opt-in and that is the solution that SaverOne has brought to the market.
The opportunities in front of SaverOne as they expand into fleets, push into international markets, launch an OEM solution for car makers, and build a tool to protect Vulnerable Road Users will have to be weighed by investors against the dilution risk related to any pending financing.
There is no doubt that distracted driving remains a huge problem around the globe, but absent significant legislative action (the EU has recently enacted some distracted driving measures to be rollout over the next few years), the current half-hearted approach to the problem (relying on driver compliance) is likely going to be the default in most markets. As more advanced features are built into new vehicles, it is likely that adoption rates of Driver Distraction Prevention Solutions like those offered by SaverOne with grow.
SaverOne is an early-stage market entrant but if you are watching for next-generation safety solutions in the transportation market then you should have it on your radar.
Pennystock
Octodec ready for the next push up to R10.87 - NB Investment TipOctodec has had a challenging year with the price constantly on the downtrend.
That was until 27 June 2023... We can see a huge wick where there was most likely buying from Smart Money and financial institutions...
Since then the support has been tested numerous times and it's since then formed a W Formation (Double Bottom)...
We do need the price to break above the neckline for further upside but things are looking good.
IMPORTANT TRADING TIP AND MEDIUM TERM INVESTMENT TIP
Also, with lower liquid and high volatile stocks, I like to extend the stop loss quite broad. I normally move the stop loss BELOW the entire pattern to give room in case there are jumpy moves along the process to stop us out...
ALSO because there aren't CFDs or derivatives, these strategy works very well for medium term investments using technicals and fundamentals.
Other indicators state the following:
Price<200
RSI>50 - Bullish
Target R10.87
ABOUT THE COMPANY:
Octodec Investments Ltd is a real estate investment trust (REIT) operating primarily in South Africa.
It was established in 1959 and is listed on the Johannesburg Stock Exchange (JSE).
Octodec focuses on property investment and property management, primarily in the commercial and residential sectors.
Company Background:
Octodec Investments Ltd is a well-established and respected real estate investment company in South Africa.
Real Estate Focus:
Octodec primarily invests in and manages a diverse portfolio of properties, including retail, commercial, and residential real estate.
Geographic Focus:
Its property portfolio is mainly situated in key urban areas within South Africa, including Johannesburg, Pretoria, and other high-demand regions.
Property Portfolio:
The company owns, manages, and leases a range of properties, including office buildings, shopping centers, and residential complexes.
Income Generation:
Octodec earns income through rental collections from its property portfolio.
Can NVTA reverse and rise?NVTA on the daily chart is in deep undervalued territory at the third lower Bollinger Band.
It put in a green engulfing candle after a Doji candle. The TTM squeeze indicator fired
a trigger while the lower TF RS line is about to cross the higer TF line and the 50 level.
The MACD lines crossed while under the histogram which is a low amplitude green.
The two most recent earnings reports were beats. Price ran 50% in late April and 60%
in early July, I believe that another run is now possible for this long trade setup. Penny stocks
like this have the ability to build momentum and upward volatility quickly.
GOEV a niche EV manufacturer LONGGOEV does not compete with TSLA. It makes special use electric vehicles
including a NASA contract apparently for vehicles to be used upon the return
to moon exploration. As a penny stock, GEOV has weak fundamentals
coupled with high trader and investor interest. Large capital institutions
have a predominant portion of the shares.
On the 15 minute chart. GOEV trended up from July 14th to Ju;y 19th and
then down to about the same price as before then trend. This was a range
of 50% demonstrating the typical high volatility of penny stocks. Based on
a set of anchored VWAP bands originating in mid- April, GOEV is currently
near the mean long multi-session VWAP. Since many shares are held by
institutions this is a price level where trading volume and volatility are
expected.
I will take a long trade here. The stop loss is the recent swing low at $0.59
with a target at $0.737 just below the POC line of the related
volume profile from an entry-by-limit order at $0.613 making for a projected
profit of 20% with a much lower risk. For chartists who follow chart patterns,
in the interval under analysis, GOEV fell from a head and shoulders pattern.
My target is the neckline of that pattern.
GOEV benefits from the general interest and trading volumes in the EV sector
at large as well as its niche with little competition.
Can VBIV jump again like earlier this month?VBIV popped 50 % to begin July and then promptly lost 75% and has been low volume and
sideways since. I have not been able to discern any catalyst for that action. Earnings show
an ongoing cash burn. In the past couple of days, the Price Volume Trend indicator has
detected a small increase in the price volume product. The Relative Trend Index (RTI) indicator
has gone from negative to positive on July 18th while the dual time frame RSI indicator
showing 1 hour TF in blue and daily TF in black has shown bullish divergence with the lines
rising over the 50 level and the blue line above the black line. Price crossed a VWAP band line
on July 18th as well. The analysis supports a bullish bias and a set up for a long trade.
I will trade long and find an entry on a 15 - 30 minute chart looking for a pivot low
to take that position. I will target 2.25 and 3.00 for the time being.
FLMD biotechology rising post earningsFLMD had earnings in May with positive earnings beating the expectation of analysts that
it would continue to lose quarter after quarter. Investors and traders have reacted with a
80% run-up in the month after those earnings. On the 30-minute chart besides the consistent
uptrend with minor corrections, what stands out for me is the increasing volumes relative
to volumes before the last earnings report. Off the chart, I find information that insider trading
with buying more shares on top of existing holdings leads me to believe that this company
expects increasing revenues and sustained earnings.
Would you buy this?With a Market Cap of only $63.717 Mil, Mullen Automotive seems ridiculously cheap at the price of $0.26 per share.
But what I have learned over time is that penny stocks are often priced low for a reason: because they deserve it! And usually, it is the management team's fault.
Will it be able to make a solid pump or a short squeeze before another share dilution or a reverse stock split?
Looking forward to read your opinion about it!
FFIE EV Penny Stock LONGFFIE is an EV pneey stock below $ 1.00 and so has delisting risk.
The 30 minute chart shows the rationale for the long trade with 300% upside.
The risk here is of a delisting which would send FFIE into the OTC market
where it could explode. This penny stock trades millions of shares per day
and trading volume has heavily increased as the price goes lower.
Given the volatility a stop loss of 20 % at $.20 is needed or even the
swing low at $.15. However, the upside technically is the 300% to get
to the YTD swing high. I believe that it could go even higher if a delisting
occurs. A reverse stock split would be a further catalyst for FFIE.
AS a basic high risk high reward scenario, I will take along position
and what will be will be.
BLUE Biotechnology New Earnings Catalyst LONGBlueBird Bio / BLUE had an earnigns report this past week showing earnings for the firat time
but revenue was far below analyst's projections. Price has appreciated 40% in the 4 weeks
since earnings which is about 500% annualized. GO BLUE.
On the daily chart, price was above VWAP and consolidating much of last fall then dropped
this YTD until the earnings report of last week. An uptrend is seen after the earnings.
This has been a significant reversal sustained over the past month
with price rising above the support / demand zone below it. At present, price is one
standard deviation below VWAP making it undervalued and ascending.
I see this as a risky long trade like many biotechology penny stocks but with a decent
probability of profit in consideration of a target of 6.15 which is the top of the long
term high volume area. the stop loss is just below the POC line of the volume profile
at 3.15 An entry at 4.62 ( limit order above SMA200 (redlne) would yield at profit of
1.50 with a risk of 0.48 making for a R:R of 3:1. Another earnings report is coming up this
week. If it is favorable, BLUE could go parabolic to hit the target in a day or two.
If not, it will be time to exit the trade.
MGRX Biotechonolgy IPO LONGMGRX a recent IPO produces a med for erectile dysfunction without FDA approval;
They are basically selling a generic version of an approved medication and bypassing
the patent protections and betting they will fly under the regulator radar apparatus.
As might be expeted this recent nano-IPO is highlly volatile. Play with it only
if you have the requisite skills to do so and only with risk capital.
it does the marketing through direct to consumer telehealth services.
>>>>>>>>>>>>>>>>>>See also the link below <<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<
On review and analysis on the 30 minute chart, the price action is squeezing
down in a flat bottom triangle likely setting up a breakout upside.
The RSI oscillator shows RSI crossing 50% from below.
Volatility is compressing down inside the triangle for a squeeze set up.
Targets are based on the supply and demand zones of the Luxalgo indicator.
The first parget is the midline between the zones while the final target
is just below the supply zone. As can be seen on the chart, the first target
is about 100% upside while the final target is 200% upside. One of the
position is closed at each target making the return 150% overall.
Stop loss is below the demand zone. A stop loss is 15% yields an overall
reward to risk ration of 10:1.
TNYA Biotechology Penny NASDAQ LONGTNYA has been in consolidation the past two days being in the flag of
a bull flag pattern on the 1H chart. Earnings about six weeks ago were
solid especially for a biotechnology stock which are generally priced
based on future potential and not current performance.
( Fundamentally TNYA is in the gene splicing /slicing place which is
perhaps the most lucrative and therapeutic of all of the various
areas in the biotechnology realm. Seemingly, its potential is
expodentially high. )
The zero lag MACD lines have crossed under the histogram which in
general can be considered as a buy signal. The histogram has flipped to
positive.
Upside to the overhead resistance zone by the Luxalgo indicator
is from an entry of about 5 to 6 or about 20%.
Very recent high relative volume as compared with
the 50 day moving average further supports a long trade at this
time. The stop loss would be $.02 below the POC line of the
volume profile.
I will play this with options to further leverage the price action.
Both options and stock are inexpensive for a small account.
BARK a dog supply speciality stock Reverses LONGBARK is the stock of a relatively young company.It is now growing
and has had positive earnings The chart shows a reversal from the
prior downtrend which started with a double top in January.
The order block indicator shows a base of buy order blocks forming the support.
Upside is 45% to the resistance of the double top and the sell order
blocks. The anchored VWAP shows that price was supported by
the line of two standard deviations below VWAP in the deep
undervalued zone. However, with the reversal, price is now targeting
the VWAP itself which also could be an initial target for trade.
Fundamentally, no matter whether a recession is impending, people will care
for their dogs and sales should not suffer. If anything, people will seek
value deals compared with brick-and-mortar sources. Not a coincidence
but another dog-related stock WOOF is on an uptrend as well.
As a penny stock, this is a risky long trade however I also see the
reward potential. The call options for expiration on 5/19 are
priced at about $10 per contract making them very affordable
way to leverage the trade.
see also the stock analyst report linked here stockanalysis.com
Trading Idea - #VersusSystems #AI Trading Idea - #VersusSystems - LONG
Entry: 0.90 USD
Target: 2.60 USD (profit +280%)
Versus Systems (NASDAQ:VS) entered definitive agreements with institutional investors for the purchase and sale of 2.5M shares at a purchase price of $0.90 per share in a registered direct offering priced at the market under Nasdaq rules.
Versus Systems is shooting up on news of a partnership with Resolve Debt. The company is known for innovating interactive audience engagement through gamification technology. Now it plans to take its mission a step further by entering the artificial intelligence (AI) race.
CYAD is set up real nice for this move up all it needs is VOLUMEThis is a sexy setup by CYAD great push down after consolidation then an immediate bounce up after soaking up the float yesterday. Now that it has broke the last previous high it will go into re accumulation. Think about other stocks that make a push down like this and how often you see it already hit the last previous level of consolidation..... apply volume here and you have a banger..... let it stagnate and it will dip back down to start over. Low Float needs volume.
by iCantw84it
01.18.23
VLTA looking juicy as it starts its Bottom bounce moveVLTA making its move.... watch the volume . Bottom bounce on TSV making all the right moves and volume 5x the avg.
iCantw84it
01.18.23
Jubilee to run up in the near futureBullish Falling wedge
Right now Jubilee is still in a range (Falling Wedge)
The sign that it'll break up is based on the previous uptrend. Price has been coming down but on a very low range and it doesn't seem quite convicing.
I want to say if the price breaks up we could see a target of R4.23
CONCERN
If the price breaks down, we could also see a target of R1.18
The analysis is neutral right now, but I'm leaning more to the long (bullish) side.
PAN AFRICA Neutral analysis but hoping upSymmetrical Triangle
Equal chance of a breakout.
Break up - Target R6.04
Break down - target - R1.00
NEUTRAL ANALYSIS
I do have hope for Pan Africa as it's one of the rare companies that deal with innovative technology for gold extraction. Also with inflation kicking in, this will pick up the price of gold which could help gold companies who are exporters.
I want to guess the break will be up, but we can only know when it happens.
LXRX PENNY BIOTECH SHORT SETUPNASDAQ:LXRX
LXRX has gained over 100% in the past month
However it appears to be forming a double top
in a potential short trade setup on the two hour chart.
The K/D crossover on the hot RSI oscillator provides
confirmation.
Short Sale Volume is rising in the past two days.
Findamentals - LXRX has a new medication for heart failure
a common medical problem with a massive market
It recently launched a public offering to raise capital
to fund general operations and in doing so
diluted the share holders. The good news is
it is unlikely to do another in the near term.
An entry would be at the current price with a stop loss
above the highest volume bar on the profile.
The first target is the POC of the volume profile
about a 15% price drop . The second target is
the pivot low on August 1st for another 15% drop.
Taking of 1/2 at each target yields an expected
23% return over a period of about 5 trading days
since drops are faster than rises.
The call options of mid September have low volumes
so I will not consider them.
SDC UPTRENDING PENNY STOCK ( on NASDAQ) 80+% monthly gainNASDAQ:SDC
SDC is the ticker for a company that makes orthodontic mouth guards
customized for each customer cutting out the orthodontists.
Recently it has been in uptrend over the past month of more gaining 80% in the
past month. The K/D crossover on the RSI supports the end of
the current micro dip making an entry point.
A good stop loss is the recent low at 1.62 while a target might
be the recent high at 2.06
The options volume of the $2 strike is fairly light.
This is a potentially low risk penny stock now set up for
a long trade.